Drug recall · May 7, 2025
Tirofiban Hydrochloride Injection 5 mg/100 mL recall
Why: Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01
- Lots / codes
Lot #: 3TF24002A, Exp 11/30/2026
- Quantity
- 18,867 bags
- Company
- Eugia US LLC, East Windsor, NJ
- Distribution
- USA nationwide.
- Initiated
- April 21, 2025 · Voluntary: Firm initiated
- Classified
- April 25, 2025
- Reported
- May 7, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tirofiban
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.